Ocugen (OCGN) Other Non-Current Liabilities (2016 - 2026)
Ocugen (OCGN) posted Other Non-Current Liabilities of $3.0 million for Q1 2026, up 84.09% on a QoQ basis from $1.6 million in Q4 2025, and up 415.01% year-over-year from $573000.0 in Q1 2025.
Ocugen (OCGN) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
Ocugen's Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Other Non-Current Liabilities rose 415.01% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 415.01% YoY) and the FY2025 annual result came in at $1.6 million, up 184.22% from the prior year.
- Other Non-Current Liabilities was $3.0 million for Q1 2026 at Ocugen, up from $1.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $3.0 million in Q1 2026 and bottomed at $244000.0 in Q4 2022.
- A 5-year average of $823857.1 and a median of $549500.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities rose 6.9% — and 2026, when it soared 415.01%.
- Ocugen's Other Non-Current Liabilities stood at $244000.0 in 2022, then jumped by 115.98% to $527000.0 in 2023, then rose by 7.02% to $564000.0 in 2024, then jumped by 184.22% to $1.6 million in 2025, then soared by 84.09% to $3.0 million in 2026.
- Business Quant data shows OCGN's Other Non-Current Liabilities at $3.0 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.95 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 583,000.00 |
| Mar 31, 2025 | 573,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Sep 30, 2024 | 554,000.00 |
| Jun 30, 2024 | 545,000.00 |
| Mar 31, 2024 | 536,000.00 |
| Dec 31, 2023 | 527,000.00 |
| Sep 30, 2023 | 497,000.00 |
| Jun 30, 2023 | 455,000.00 |
| Mar 31, 2023 | 309,000.00 |
| Dec 31, 2022 | 244,000.00 |
| Mar 31, 2020 | 3,940.00 |
| Dec 31, 2019 | 9,755.00 |
| Jun 30, 2019 | 15,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Dec 31, 2018 | 37,459.00 |
| Sep 30, 2018 | 2.16 Mn |